Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NTNX Stock Summary
In the News
NTNX Financial details
Company Rating
Sell
Market Cap
15.45B
Income
-77.53M
Revenue
2.02B
Book val./share
-2.51
Cash/share
6.74
Dividend
-
Dividend %
-
Employees
6.45K
Optionable
No
Shortable
Yes
Earnings
22 May 2024
P/E
-198.85
Forward P/E
-
PEG
21.96
P/S
7.65
P/B
-25.2
P/C
8.71
P/FCF
40.32
Quick Ratio
1.58
Current Ratio
1.67
Debt / Equity
-2.1
LT Debt / Equity
-2.04
-
-
EPS (TTM)
-0.34
EPS next Y
-
EPS next Q
-
EPS this Y
-69.89%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-20.49%
Revenue last 5Y
8.55%
Revenue Q/Q
10.6%
EPS Q/Q
-298.17%
-
-
-
-
SMA20
-3.13%
SMA50
8.77%
SMA100
55%
Inst Own
69.53%
Inst Trans
0.88%
ROA
-3%
ROE
11%
ROC
-0.03%
Gross Margin
84%
Oper. Margin
-2%
Profit Margin
-4%
Payout
-30%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
23.345-66.99
52W High
-11.03%
52W Low
+155.3%
RSI
40
Rel Volume
0.58
Avg Volume
2.86M
Volume
1.67M
Perf Week
-8.61%
Perf Month
-10.83%
Perf Quarter
69.12%
Perf Half Y
52.92%
-
-
-
-
Beta
1.277
-
-
Volatility
1.51%, 1.81%
Prev Close
-1.36%
Price
58.72
Change
-3.2%
NTNX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-07-31
Metric | History | 2019-07-31 | 2020-07-31 | 2021-07-31 | 2022-07-31 | 2023-07-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.83 | 6.72 | 6.75 | 7.17 | 7.99 | |
Net income per share | -3.43 | -4.48 | -5.01 | -3.62 | -1.09 | |
Operating cash flow per share | 0.23 | -0.82 | -0.48 | 0.31 | 1.17 | |
Free cash flow per share | -0.42 | -1.28 | -0.77 | 0.08 | 0.89 | |
Cash per share | 5.02 | 3.7 | 5.88 | 6.01 | 6.16 | |
Book value per share | 1.03 | -1.41 | -4.9 | -3.58 | -3.03 | |
Tangible book value per share | -0.36 | -2.62 | -5.95 | -4.49 | -3.85 | |
Share holders equity per share | 1.03 | -1.41 | -4.9 | -3.58 | -3.03 | |
Interest debt per share | 3.32 | 3.47 | 6.13 | 6.77 | 5.92 | |
Market cap | 4.11B | 4.32B | 7.44B | 3.35B | 7.04B | |
Enterprise value | 4.17B | 4.65B | 8.34B | 4.38B | 7.85B | |
P/E ratio | -6.62 | -4.95 | -7.19 | -4.21 | -27.67 | |
Price to sales ratio | 3.32 | 3.3 | 5.33 | 2.12 | 3.78 | |
POCF ratio | 97.45 | -27.02 | -74.51 | 49.66 | 25.86 | |
PFCF ratio | -53.87 | -17.33 | -46.94 | 181.46 | 34.03 | |
P/B Ratio | 21.99 | -15.71 | -7.35 | -4.24 | -9.96 | |
PTB ratio | 21.99 | -15.71 | -7.35 | -4.24 | -9.96 | |
EV to sales | 3.37 | 3.55 | 5.98 | 2.77 | 4.21 | |
Enterprise value over EBITDA | -8.02 | -6.32 | -14.72 | -11.86 | -60.02 | |
EV to operating cash flow | 98.93 | -29.06 | -83.52 | 64.89 | 28.81 | |
EV to free cash flow | -54.69 | -18.63 | -52.61 | 237.09 | 37.91 | |
Earnings yield | -0.15 | -0.2 | -0.14 | -0.24 | -0.04 | |
Free cash flow yield | -0.02 | -0.06 | -0.02 | 0.01 | 0.03 | |
Debt to equity | 3.06 | -2.34 | -1.17 | -1.81 | -1.86 | |
Debt to assets | 0.32 | 0.36 | 0.52 | 0.6 | 0.52 | |
Net debt to EBITDA | -0.12 | -0.44 | -1.59 | -2.78 | -6.15 | |
Current ratio | 2.13 | 1.44 | 1.68 | 1.44 | 1.64 | |
Interest coverage | -20.4 | -26.47 | -8.27 | -7.53 | -3.23 | |
Income quality | -0.07 | 0.18 | 0.1 | -0.08 | -1.07 | |
Dividend Yield | 0 | 0 | 0.01 | 0.02 | 0.01 | |
Payout ratio | 0 | 0 | -0.06 | -0.09 | -0.14 | |
Sales general and administrative to revenue | 0.1 | 0.1 | 0.11 | 0.11 | 0.12 | |
Research and developement to revenue | 0.41 | 0.42 | 0.4 | 0.36 | 0.31 | |
Intangibles to total assets | 0.14 | 0.13 | 0.1 | 0.09 | 0.08 | |
Capex to operating cash flow | -2.81 | 0.56 | 0.59 | -0.73 | -0.24 | |
Capex to revenue | -0.1 | -0.07 | -0.04 | -0.03 | -0.04 | |
Capex to depreciation | -1.53 | -0.95 | -0.62 | -0.56 | -0.86 | |
Stock based compensation to revenue | 0.25 | 0.27 | 0.26 | 0.22 | 0.17 | |
Graham number | 8.93 | 11.93 | 23.5 | 17.08 | 8.63 | |
ROIC | -0.8 | -1.62 | -2.23 | -0.61 | -0.32 | |
Return on tangible assets | -0.4 | -0.57 | -0.5 | -0.37 | -0.11 | |
Graham Net | -2.67 | -5.69 | -9.13 | -7.49 | -6.94 | |
Working capital | 675.9M | 333.82M | 634.37M | 507.76M | 725.63M | |
Tangible asset value | -65.06M | -509.63M | -1.23B | -991.26M | -897.25M | |
Net current asset value | -323.94M | -949.5M | -1.73B | -1.5B | -1.37B | |
Invested capital | 3.06 | -2.34 | -1.17 | -1.81 | -1.86 | |
Average receivables | 251.88M | 244M | 211.65M | 152.67M | 140.91M | |
Average payables | 69.78M | 64.04M | 50.54M | 45.99M | 37.43M | |
Average inventory | 39.96M | 57.47M | 89.81M | 141.32M | 145.86M | |
Days sales outstanding | 72.48 | 67.69 | 47.32 | 28.76 | 30.81 | |
Days payables outstanding | 88.87 | 68.79 | 58.84 | 51.06 | 32.88 | |
Days of inventory on hand | 55.49 | 87.46 | 138.71 | 195.15 | 131.85 | |
Receivables turnover | 5.04 | 5.39 | 7.71 | 12.69 | 11.85 | |
Payables turnover | 4.11 | 5.31 | 6.2 | 7.15 | 11.1 | |
Inventory turnover | 6.58 | 4.17 | 2.63 | 1.87 | 2.77 | |
ROE | -3.32 | 3.17 | 1.02 | 1.01 | 0.36 | |
Capex per share | -0.65 | -0.46 | -0.28 | -0.22 | -0.28 |
Quarterly Fundamentals Overview
Last date of statement is 2024-01-31 for Q2
Metric | History | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 | 2024-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.1 | 1.91 | 2.08 | 2.12 | 2.32 | |
Net income per share | -0.31 | -0.35 | -0.06 | -0.07 | 0.13 | |
Operating cash flow per share | 0.32 | 0.27 | 0.25 | 0.6 | 0.76 | |
Free cash flow per share | 0.27 | 0.18 | 0.19 | 0.55 | 0.67 | |
Cash per share | 5.65 | 5.79 | 6.04 | 6.51 | 6.74 | |
Book value per share | -3.37 | -3.36 | -2.97 | -2.66 | -2.51 | |
Tangible book value per share | -4.22 | -4.18 | -3.77 | -3.44 | -3.3 | |
Share holders equity per share | -3.37 | -3.36 | -2.97 | -2.66 | -2.51 | |
Interest debt per share | 5.68 | 5.62 | 5.6 | 5.62 | 5.33 | |
Market cap | 6.46B | 5.75B | 7.18B | 8.74B | 13.7B | |
Enterprise value | 7.36B | 6.63B | 7.99B | 9.47B | 14.39B | |
P/E ratio | -22.83 | -17.72 | -135.14 | -137.82 | 104.47 | |
Price to sales ratio | 13.29 | 12.83 | 14.53 | 17.1 | 24.25 | |
POCF ratio | 87.25 | 89.5 | 123.18 | 60.08 | 73.52 | |
PFCF ratio | 102.58 | 135.53 | 157.83 | 65.98 | 84.26 | |
P/B Ratio | -8.26 | -7.29 | -10.15 | -13.61 | -22.4 | |
PTB ratio | -8.26 | -7.29 | -10.15 | -13.61 | -22.4 | |
EV to sales | 15.13 | 14.77 | 16.16 | 18.53 | 25.46 | |
Enterprise value over EBITDA | -236.66 | -134.51 | 1.34K | 758.56 | 260.48 | |
EV to operating cash flow | 99.33 | 103.06 | 136.96 | 65.08 | 77.2 | |
EV to free cash flow | 116.78 | 156.06 | 175.49 | 71.48 | 88.48 | |
Earnings yield | -0.01 | -0.01 | 0 | 0 | 0 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
Debt to equity | -1.66 | -1.66 | -1.86 | -2.09 | -2.1 | |
Debt to assets | 0.55 | 0.55 | 0.52 | 0.52 | 0.47 | |
Net debt to EBITDA | -28.78 | -17.7 | 134.79 | 58.33 | 12.42 | |
Current ratio | 1.52 | 1.53 | 1.64 | 1.74 | 1.67 | |
Interest coverage | -3.56 | -9.6 | -0.7 | -0.35 | 2.22 | |
Income quality | -1.04 | -0.79 | -4.39 | -9.18 | 5.68 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | -0.12 | 0 | -0.87 | 0 | |
Sales general and administrative to revenue | 0.17 | 0.12 | 0.1 | 0.09 | 0.09 | |
Research and developement to revenue | 0.29 | 0.33 | 0.3 | 0.3 | 0.28 | |
Intangibles to total assets | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | |
Capex to operating cash flow | -0.15 | -0.34 | -0.22 | -0.09 | -0.13 | |
Capex to revenue | -0.02 | -0.05 | -0.03 | -0.03 | -0.04 | |
Capex to depreciation | -0.56 | -1.11 | -0.74 | -0.72 | -1.31 | |
Stock based compensation to revenue | 0.18 | 0.16 | 0.15 | 0.16 | 0.15 | |
Graham number | 4.81 | 5.11 | 1.93 | 1.98 | 2.76 | |
ROIC | -0.09 | -0.12 | -0.03 | -0.01 | 0.04 | |
Return on tangible assets | -0.03 | -0.04 | -0.01 | -0.01 | 0.01 | |
Graham Net | -7.08 | -7.11 | -6.81 | -6.12 | -6.36 | |
Working capital | 579.48M | 596.06M | 725.63M | 818.38M | 779.01M | |
Tangible asset value | -977.88M | -981.66M | -897.25M | -830.89M | -803.8M | |
Net current asset value | -1.46B | -1.46B | -1.37B | -1.29B | -1.4B | |
Invested capital | -1.66 | -1.66 | -1.86 | -2.09 | -2.1 | |
Average receivables | 122.41M | 148.13M | 146.16M | 145.48M | 164.82M | |
Average payables | 37.45M | 39.15M | 32.08M | 32.86M | 37.67M | |
Average inventory | 164.59M | 137.8M | 116.87M | 123.1M | 63.1M | |
Days sales outstanding | 29.82 | 27.1 | 28.64 | 23.55 | 31.2 | |
Days payables outstanding | 45.69 | 36.97 | 33.48 | 39.31 | 43.59 | |
Days of inventory on hand | 167.82 | 122.83 | 134.23 | 138.58 | 0 | |
Receivables turnover | 3.02 | 3.32 | 3.14 | 3.82 | 2.88 | |
Payables turnover | 1.97 | 2.43 | 2.69 | 2.29 | 2.06 | |
Inventory turnover | 0.54 | 0.73 | 0.67 | 0.65 | 0 | |
ROE | 0.09 | 0.1 | 0.02 | 0.02 | -0.05 | |
Capex per share | -0.05 | -0.09 | -0.05 | -0.05 | -0.1 |
NTNX Frequently Asked Questions
What is Nutanix, Inc. stock symbol ?
Nutanix, Inc. is a US stock , located in San jose of Ca and trading under the symbol NTNX
What is Nutanix, Inc. stock quote today ?
Nutanix, Inc. stock price is $58.72 today.
Is Nutanix, Inc. stock public?
Yes, Nutanix, Inc. is a publicly traded company.